Abstract
To summarize, the discovery of unexpected benefits of ARBs and ACEIs, unrelated to BP lowering, suggests a new paradigm to understand the genesis and progression of renal disease in diabetic and perhaps other patients. Novel therapeutic strategies will, hopefully, ensue. © 2006 Oxford University Press.
Author supplied keywords
Cite
CITATION STYLE
APA
Miyata, T., & van Ypersele de Strihou, C. (2006, April). Renoprotection of angiotensin receptor blockers: Beyond blood pressure lowering. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfl013
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free